CStone Pharmaceuticals — Board/Management Information 2022

May 31, 2022

==> picture [116 x 37] intentionally omitted <==

CStone Pharmaceuticals 基石藥業

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2616)

LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

The members of the board of directors (the “ Board ”) of CStone Pharmaceuticals (the “ Company ”) are set out below.

Executive director

Dr. Frank Ningjun Jiang (Chief Executive Officer)

Non-executive directors

• Dr. Wei Li (Chairman)

• Mr. Kenneth Walton Hitchner III

• Mr. Yanling Cao

• Mr. Xianghong Lin

• Mr. Edward Hu

Independent non-executive directors

• Dr. Paul Herbert Chew

• Mr. Ting Yuk Anthony Wu

• Mr. Hongbin Sun

The Board has four Board committees. The table below provides the membership information of these committees on which each director of the Company serves.

	Audit Committee	Compensation Committee	Nomination Committee	Strategy Committee	Investment Committee
Dr. Frank Ningjun Jiang				C
Dr. Wei Li		M	C
Mr. Kenneth Walton Hitchner III					M
Mr. YanlingCao			M
Mr. XianghongLin
Mr. Edward Hu				M	C
Dr. Paul Herbert Chew	M	M	M	M
Mr. TingYuk AnthonyWu	M	C	M
Mr. Hongbin Sun	C		M		M

Notes:

• C Chairman of the relevant Board committee

• M Member of the relevant Board committee

May 31, 2022